Dirk Scharn
Impact in
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Chemical Synthesis and Analysis 4
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 2
-
- Multiple Myeloma Research and Treatments 3
- Blood Coagulation and Thrombosis Mechanisms 2
- Co-authors
- Elsa Locardi (5 shared papers)Uwe Richter (5 shared papers)Karsten Schnatbaum (5 shared papers)Harald Engelhardt (6 shared papers)Daniel Gerlach (4 shared papers)Onur Kaya (3 shared papers)Thomas Gerstberger (3 shared papers)Anke Baum (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Cancer Research (3 papers)Journal of Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- AustriaGermanyUnited Kingdom
In The Last Decade
Dirk Scharn
14 papers receiving 178 citations
Peers
Comparison fields: 5 of 46
- Hematology 35
- Immunology and Allergy 18
- Genetics 26
- Immunology 47
- Molecular Biology 122
Countries citing papers authored by Dirk Scharn
This map shows the geographic impact of Dirk Scharn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Scharn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Scharn more than expected).
Fields of papers citing papers by Dirk Scharn
This network shows the impact of papers produced by Dirk Scharn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Scharn. The network helps show where Dirk Scharn may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Scharn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 66 | |
| 2 | 2006 | 38 | |
| 3 | 2009 | 21 | |
| 4 | 2012 | 14 | |
| 5 | 2013 | 10 | |
| 6 | 2009 | 6 | |
| 7 | 2009 | 5 | |
| 8 | 2009 | 5 | |
| 9 | 2009 | 5 | |
| 10 | 2009 | 4 | |
| 11 | 2015 | 4 | |
| 12 | 2016 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2017 | 0 |
About Dirk Scharn
Dirk Scharn is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Immunology, having authored 15 papers that have together received 181 indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Chemical Synthesis and Analysis (4 papers), Protein Degradation and Inhibitors (3 papers), Multiple Myeloma Research and Treatments (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Cell Adhesion Molecules Research (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Hematology (35 citations), Immunology and Allergy (18 citations), Genetics (26 citations), Immunology (47 citations) and Molecular Biology (122 citations). Dirk Scharn has collaborated with scholars based in Austria, Germany and United Kingdom. Frequent co-authors include Elsa Locardi, Uwe Richter, Karsten Schnatbaum, Harald Engelhardt, Daniel Gerlach, Onur Kaya, Thomas Gerstberger, Anke Baum, Heiko Hawlisch and Johannes Popow. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.